Results 131 to 140 of about 3,667 (197)

Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. [PDF]

RSC Adv
Monika, Sharma B, Awasthi SK.
europepmc   +1 more source

Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border. [PDF]

Antimicrob Agents Chemother, 2015
Saunders DL, Chaorattanakawee S, Gosi P, Lanteri C, Somethy S, Kuntawunginn W, Ittiverakul M, Chann S, Gregory C, Chuor CM, Prom S, Spring MD, Lon C.   +12 more
europepmc   +1 more source

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment. [PDF]

Malar J, 2014
Maude RJ, Nguon C, Dondorp AM, White LJ, White NJ.   +4 more
europepmc   +1 more source

4-nitrobenzoate inhibits 4-hydroxybenzoate polyprenyltransferase in malaria parasites and enhances atovaquone efficacy. [PDF]

FEBS Lett
Verdaguer IB, Santos MF, Filho MM, Castro GO, Hernández A, Peres MA, Katzin AM, Crispim M.   +7 more
europepmc   +1 more source

Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports. [PDF]

Antimicrob Agents Chemother, 2014
Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, Atovaquone-Proguanil Treatment Failure Study Group.   +5 more
europepmc   +1 more source

Molecular Surveillance of <i>Plasmodium vivax</i> and <i>Plasmodium falciparum</i> Drug Resistance Genes in the Republic of Korea: 2022-2025. [PDF]

Pathogens
Jung H, Shin HI, Ku B, Park E, Lee MR, Ju JW, Lee HI.   +6 more
europepmc   +1 more source

An Increase in Imported <i>Plasmodium vivax</i> Malaria in New York City: Clinical and Demographic Trends Following Recent Migration. [PDF]

Open Forum Infect Dis
Berto CG, Policarpio MA, Vargas-Pena C, Antwi M, Slavinski S, Abdool A, King RN, Kojaoghlanian T, Daily JP, Prasad N, Velasquez MR, Ridpath AD, Coyle CM.   +12 more
europepmc   +1 more source

Better late than never: defining the ideal vaccine that targets pre-erythrocytic malaria infection. [PDF]

EMBO Mol Med
Rochfort Peters GM, Baum J.
europepmc   +1 more source

Malaria Prevention: Progress to Date. [PDF]

Drugs
Grobusch MP, Schnyder JL, Schlagenhauf P, de Jong HK, Hanscheid T.   +4 more
europepmc   +1 more source

Targeting Mitochondrial Function in <i>Plasmodium falciparum</i>: Insight into Antimalarial Drugs and the Emerging Role of <i>Saccharomyces cerevisiae</i> as a Model System. [PDF]

Int J Mol Sci
Greco S, Assalve G, Lunetti P, Kayentao K, Dara A, Scaramuzzi D, Zara V, Ferramosca A.   +7 more
europepmc   +1 more source